PMC:7358770 / 20441-20630
Annnotations
LitCovid_Glycan-Motif-Structure
{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T35","span":{"begin":56,"end":67},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"}],"text":"elves from immune attack [22]. For example, fucosylated chondroitin sulfate was effective in blocking laboratory strain HIV-1IIIB entry and replication (4.26 μg/mL and 0.73 μg/mL, respectiv"}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T209","span":{"begin":56,"end":75},"obj":"Body_part"},{"id":"T210","span":{"begin":120,"end":123},"obj":"Body_part"}],"attributes":[{"id":"A209","pred":"fma_id","subj":"T209","obj":"http://purl.org/sig/ont/fma/fma82837"},{"id":"A210","pred":"fma_id","subj":"T210","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":"elves from immune attack [22]. For example, fucosylated chondroitin sulfate was effective in blocking laboratory strain HIV-1IIIB entry and replication (4.26 μg/mL and 0.73 μg/mL, respectiv"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"734","span":{"begin":120,"end":125},"obj":"Species"},{"id":"748","span":{"begin":56,"end":75},"obj":"Chemical"}],"attributes":[{"id":"A734","pred":"tao:has_database_id","subj":"734","obj":"Tax:11676"},{"id":"A748","pred":"tao:has_database_id","subj":"748","obj":"MESH:D002809"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"elves from immune attack [22]. For example, fucosylated chondroitin sulfate was effective in blocking laboratory strain HIV-1IIIB entry and replication (4.26 μg/mL and 0.73 μg/mL, respectiv"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T212","span":{"begin":26,"end":28},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"}],"text":"elves from immune attack [22]. For example, fucosylated chondroitin sulfate was effective in blocking laboratory strain HIV-1IIIB entry and replication (4.26 μg/mL and 0.73 μg/mL, respectiv"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T324","span":{"begin":56,"end":75},"obj":"Chemical"},{"id":"T325","span":{"begin":68,"end":75},"obj":"Chemical"}],"attributes":[{"id":"A324","pred":"chebi_id","subj":"T324","obj":"http://purl.obolibrary.org/obo/CHEBI_37397"},{"id":"A325","pred":"chebi_id","subj":"T325","obj":"http://purl.obolibrary.org/obo/CHEBI_16189"}],"text":"elves from immune attack [22]. For example, fucosylated chondroitin sulfate was effective in blocking laboratory strain HIV-1IIIB entry and replication (4.26 μg/mL and 0.73 μg/mL, respectiv"}
LitCovid-PD-GlycoEpitope
{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T13","span":{"begin":56,"end":67},"obj":"GlycoEpitope"}],"attributes":[{"id":"A13","pred":"glyco_epitope_db_id","subj":"T13","obj":"http://www.glycoepitope.jp/epitopes/EP0081"}],"text":"elves from immune attack [22]. For example, fucosylated chondroitin sulfate was effective in blocking laboratory strain HIV-1IIIB entry and replication (4.26 μg/mL and 0.73 μg/mL, respectiv"}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T567","span":{"begin":11,"end":17},"obj":"UBERON:0002405"},{"id":"T568","span":{"begin":56,"end":75},"obj":"CHEBI:37397;CHEBI:37397"},{"id":"T569","span":{"begin":140,"end":151},"obj":"GO:0006260"},{"id":"T75769","span":{"begin":50,"end":62},"obj":"GO:0065003"},{"id":"T36200","span":{"begin":63,"end":71},"obj":"GO:0032993"},{"id":"T9017","span":{"begin":71,"end":78},"obj":"GO:0032993;CHEBI:60027;CHEBI:60027"},{"id":"T57402","span":{"begin":79,"end":88},"obj":"GO:0032993"},{"id":"T93024","span":{"begin":172,"end":177},"obj":"NCBITaxon:10239"}],"text":"elves from immune attack [22]. For example, fucosylated chondroitin sulfate was effective in blocking laboratory strain HIV-1IIIB entry and replication (4.26 μg/mL and 0.73 μg/mL, respectiv"}
MyTest
{"project":"MyTest","denotations":[{"id":"734","span":{"begin":120,"end":125},"obj":"Species"},{"id":"748","span":{"begin":56,"end":75},"obj":"Chemical"}],"attributes":[{"id":"A734","pred":"tao:has_database_id","subj":"734","obj":"Tax:11676"},{"id":"A748","pred":"tao:has_database_id","subj":"748","obj":"MESH:D002809"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"elves from immune attack [22]. For example, fucosylated chondroitin sulfate was effective in blocking laboratory strain HIV-1IIIB entry and replication (4.26 μg/mL and 0.73 μg/mL, respectiv"}